C-Y9UACambridge Epigenetix
6-base genome, multiomics, epigenetic sequencing
research tools
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-Y9UA
C-Y9UAC-Y9UA6-base genome, multiomics, epigenetic sequencing
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Cambridge Epigenetix states that epigenetics can help address major global challenges and improve health and wellness for everyone. The company says progress comes from collaboration across complementary expertise, and it presents DNA modification measurement and analysis as a way to deepen biological understanding and support biomarker discovery and development.
SourceCambridge Epigenetix presents itself as a leader in epigenetics that believes advanced chemical biology can produce ground-breaking, easy-to-use, high-quality tools for studying DNA methylation. The company emphasizes that its TrueMethyl kits and oxBS-Seq technology enable quantitative, single-base-resolution sequencing of 5-hydroxymethylcytosine and 5-methylcytosine, positioning these capabilities as important for advancing epigenetics research.
SourceCambridge Epigenetix presents itself as a company leading an epigenetics revolution by applying chemical biology expertise to create high-quality, easy-to-use research tools. It states that its TrueMethyl kits, based on oxBS-Seq technology developed at the University of Cambridge, enable quantitative, single-base-resolution sequencing of hydroxymethylcytosine (5-hmC) and methylcytosine (5-mC), reflecting a belief that precise measurement of these epigenetic marks is important for advancing epigenetics research.
SourceCambridge Epigenetix presents itself as a company advancing the "epigenetics revolution" by applying chemical biology expertise to create high-quality, easy-to-use tools for epigenetics research. It states that its TrueMethyl kits, based on oxBS-Seq technology developed at the University of Cambridge, enable quantitative single-base resolution sequencing of 5-hydroxymethylcytosine (5hmC) and 5-methylcytosine (5mC), reflecting a belief that accurately distinguishing and measuring these epigenetic marks is important for understanding the epigenome.
SourceCambridge Epigenetix presents itself as a company leading an epigenetics revolution by applying chemical biology to create high-quality, easy-to-use research tools. It states that its innovative TrueMethyl kits, based on oxBS-Seq technology developed at the University of Cambridge, enable quantitative, single-base resolution sequencing of 5-hydroxymethylcytosine (5hmC) and 5-methylcytosine (5mC), reflecting a belief that these epigenetic marks are important to study and that better measurement tools can advance research.
Source